MasTec Director Sells $2.4 Million in Company Stock
MTZ has more than doubled off its 52-week low of $153.82.
Summary
MasTec Director Ernst Csiszar sold 6,500 shares of common stock for $2.41 million, reducing his direct holdings to 10,816 shares.
Key Events · Ownership and Investor Activity · MTZ
-
Director Sells Shares
Ernst Csiszar, a Director at MasTec, sold 6,500 shares of common stock on the open market for a total value of $2,412,605 at an average price of $371.17 per share.
-
Reduced Holdings
Following this transaction, Mr. Csiszar's direct holdings in MasTec common stock decreased to 10,816 shares.
-
Context of Recent Insider Sales
This sale contributes to a recent pattern of insider distribution, including a $1.25 million sale by another director in May, despite the company reporting exceptionally strong first-quarter results in April.
Analysis · MTZ · Real Estate & Construction
Director Ernst Csiszar sold a substantial amount of MasTec stock, totaling over $2.4 million. This transaction, while a small percentage of the company's large market capitalization, represents a significant personal disposition by a board member. It follows recent strong first-quarter earnings reported by MasTec, and adds to a pattern of insider distribution, including another director's $1.25 million sale last month. Such sales can be interpreted by investors as a lack of conviction in future upside at current price levels, or simply as personal liquidity management.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MTZ was trading at $362.85 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $28.8B. The 52-week trading range was $153.82 to $441.43. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.